decisionhealth Newsletters, Part B News - 2016 Issue 10 (October)
Small price changes make big differences for most-used drugs in October ASP list
Subscribe or sign in to view the full article.
Article Overview
This article covers Medicare Part B average sales price updates for October 2016, with emphasis on the most frequently billed drugs and contrast material used in outpatient and radiology settings. It is relevant to coding, billing, and reimbursement professionals who track ASP-based payment changes, utilization patterns, and CMS pricing file updates.
Why This Topic Matters
Even small ASP changes can affect reimbursement across high-volume drugs and supplies, so this update helps readers monitor payment shifts that may have meaningful financial impact over time.
Article Sections
-
Overview of October 2016 ASP pricing changes
Introduces the scope of the CMS ASP update and explains why small pricing changes can matter in high-volume settings.
-
Most-used drugs and utilization trends
Summarizes which drugs appear most frequently in claims data and notes broader utilization patterns across common therapies.
-
Drug pricing table and payment limit changes
Presents a comparison of selected drugs, claim volumes, and payment limit changes from one pricing cycle to the next.
What You Will Learn
- How October 2016 ASP updates affected commonly billed drugs
- Which high-volume drugs and contrast materials were highlighted in the pricing review
- How ASP-based payment changes are presented in CMS pricing files
- Why utilization volume can amplify the effect of small unit price changes
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Radiology practices
- Hospital reimbursement teams
- Compliance teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com